Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RIBACIR: Ribavirin Monotherapy in Advanced Chronic Hepatitis C
NCT00840489Phase 2Terminated
- Sponsor
- Ramón y Cajal University Hospital
- Start
- Jan 2009
- Primary completion
- Dec 2012
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of ribavirin in hepatitis C (HCV), sponsored by Ramón y Cajal University Hospital. Started Jan 2009; status: terminated.
02
Drugs
ribavirin
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00840489.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00840489.